Skip to content

Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet

Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030382
Enrollment
Unknown
Registered
2020-02-17
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia (COVID-19)

Interventions

Case series:routine treatment+indirect moxibustion

Sponsors

Hubei Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criterias for novel coronavirus pneumonia during the medical observation period, light type (the syndrome of cold and damp stagnating lungs), ordinary type (the syndrome of lung block by cold and damp), and recovery period (qi deficiency of the spleen and the lung syndrome); 2. Aged 18 to 65 years old; 10-day spacer 3. Voluntarily received inderect moxibustion for at least 10 days; 4. Voluntarily test and abide by the relevant management regulations of the hospital, and be able to cooperate in completing the various inspections.

Exclusion criteria

Exclusion criteria: 1. If the researcher judges that a previous or current disease may affect the outcome of participating in the trial or study: severe lung disease, diabetes, cardiovascular and cerebrovascular disease, liver and kidney disease, malignant tumor, neuropsychiatric disease and other diseases that seriously affect survival; 2. Suffering from diseases that seriously affect the immune system: such as HIV infection, splenectomy, organ transplantation, etc.; 3. Pregnant and lactating women; 4. Those who are allergic to moxibustion or Chinese medicine, or allergies; 5. Hyperthermia, irritability Patients with intense heat; 6. local skin damage caused by the application is not suitable; 7. those who have participated in other clinical trials within the past 3 months; 8. researchers who are not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
pulmonary iconography;

Secondary

MeasureTime frame
temperature;Pulmonary imaging;lymphocyte;Nucleic acid test results;

Countries

China

Contacts

Public ContactZhongyu Zhou

Hubei Provincial Hospital of TCM

2209447940@qq.com+86 18672308659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026